Exane Derivatives’s Opko Health OPK Stock Holding History

Exane Derivatives’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-38,416	Closed	-$59.5K	–	730
2019 Q4	$59.5K	Hold	38,416	–	–	0.01%	353
2019 Q3	$80.3K	Buy	38,416 +4,795	+14%	+$9.8K	0.01%	336
2019 Q2	$82K	Buy	+33,621	New	+$73.4K	0.01%	352

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Exane Derivatives's OPK Position: Q1 2020 in Review

Exane Derivatives sold out of Opko Health (OPK) in Q1 2020, closing a stake of 38,416 shares — an estimated $59.5K sold.

Exane Derivatives first reported a position in OPK in Q2 2019 and held it in 3 quarters. The position peaked at $82K in Q2 2019. 181 funds tracked by Wall St. Rank hold OPK as of Q1 2020.

Exane Derivatives reported no remaining Opko Health position as of Q1 2020 after selling out during the quarter.
Exane Derivatives sold 38,416 Opko Health shares in Q1 2020, an estimated $59.5K.
Exane Derivatives first reported a position in Opko Health in Q2 2019 and held it in 3 quarters.
Exane Derivatives's Opko Health position peaked at $82K in Q2 2019.
181 funds tracked by Wall St. Rank held Opko Health as of Q1 2020.

Based on Exane Derivatives's 13F filing for Q1 2020, filed 17 Apr 2020.